FDA Inspection
Lupin LimitedLupin Limited – FDA Inspection, Nov 23, 2022
Record Details
This FDA Inspection record concerns Lupin Limited, with an inspection on November 23, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lupin Limited
- Inspection Date
- November 23, 2022
- Product Type
- Drugs
View Company Profile
ID · f9abe983-6d55-453b-b290-d2772c179cf1
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1191374
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Lupin Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 4, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 30, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2008 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lupin Limited
- FDA Inspection 1073522 - 2018-12-04
- FDA Inspection 962120 - 2016-02-19
- FDA Inspection 748307 - 2011-09-23
- FDA Inspection 632615 - 2009-11-30
- FDA Inspection 552469 - 2008-11-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.